Re: A phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: Background and rationale of the radiotherapydadjuvant versus early salvage (RAVES) trial: Editorial comment

Samir S. Taneja

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)538
Number of pages1
JournalJournal of Urology
Issue number2
StatePublished - Feb 1 2015

ASJC Scopus subject areas

  • Urology

Cite this